Can Improving Pharmaceutical Patent Quality Promote Competition and Reduce Drug Prices?
Bhaven N. Sampat, Columbia University
Jan 01, 2023 - Jun 30, 2023
Summary of the Project:
To lower drug prices, Congress, the Food and Drug Administration, and the Patent Office are considering reforms to the system for granting and enforcing pharmaceutical patents, including initiatives to target patent quality through the restriction of “secondary” patents. This study will investigate the feasibility of promoting competition and reducing prices through restricting secondary patents. Study findings will inform current policy initiatives on this approach to reducing drug prices.